Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tippmann-Peikert, M.
Right arrow Articles by Silber, M. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tippmann-Peikert, M.
Right arrow Articles by Silber, M. H.
NEUROLOGY 2007;68:301-303
© 2007 American Academy of Neurology

Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists

M. Tippmann-Peikert, MD, J. G. Park, MD, B. F. Boeve, MD, J. W. Shepard, MD and M. H. Silber, MB, ChB

From the Mayo Clinic Sleep Disorders Center (M.T.-P., J.G.P., B.F.B., J.W.S., M.H.S.), Department of Neurology (M.T.-P., B.F.B., M.H.S.), and Division of Pulmonary and Critical Care Medicine (M.T.-P., J.G.P., J.W.S.), Mayo Clinic College of Medicine, Rochester, MN.

Address correspondence and reprint requests to Dr. M. Tippmann-Peikert, Mayo Clinic Sleep Disorders Center, Eisenberg Bldg. 8 G, 200 First Street SW, Rochester, MN 55905; e-mail: tippmannpeikert.maja{at}mayo.edu

Pathologic gambling is an impulse control disorder previously reported to complicate dopamine agonist therapy in patients with Parkinson disease. It has not been described in association with dopamine agonist therapy of other conditions. We report three patients treated in our sleep disorders center who developed pathologic gambling while receiving treatment with dopamine agonists for restless legs syndrome.


Disclosure: The authors report no conflicts of interest.

Received May 23, 2006. Accepted in final form October 17, 2006.




This article has been cited by other articles:


Home page
Obstet GynecolHome page
Pramipexole (Mirapex) for Restless Legs Syndrome
Obstet. Gynecol., July 1, 2007; 110(1): 178 - 179.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by AAN Enterprises, Inc.